• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露于1,1-二甲基肼后对小鼠淋巴细胞膜电位、细胞内游离钙和白细胞介素-2受体表达的评估。

Evaluation of murine lymphocyte membrane potential, intracellular free calcium, and interleukin-2 receptor expression upon exposure to 1,1-dimethylhydrazine.

作者信息

Frazier D E, Tarr M J, Olsen R G

机构信息

Department of Veterinary Pathobiology, Ohio State University, Columbus 43210.

出版信息

Toxicol Lett. 1992 Jun;61(1):27-37. doi: 10.1016/0378-4274(92)90060-w.

DOI:10.1016/0378-4274(92)90060-w
PMID:1609436
Abstract

The effects of 1,1-dimethylhydrazine (UDMH) on several early events associated with lymphocyte activation were examined. The concentration of intracellular calcium ([Ca2+]i) and membrane potential of murine lymphocytes were found to be altered upon exposure to UDMH; [Ca2+]i was increased in murine thymocytes, while splenocytes exhibited membrane hyperpolarization. In addition, interleukin-2 receptor expression induced by in-vitro concanavalin A stimulation of murine splenocytes at 24 and 48 h in the presence of UDMH was not affected. UDMH may interfere with the ability of these two distinct lymphocyte populations to regulate normal ionic fluctuations, thus contributing to altered immune responsiveness.

摘要

研究了偏二甲肼(UDMH)对与淋巴细胞激活相关的几个早期事件的影响。发现暴露于UDMH后,小鼠淋巴细胞的细胞内钙浓度([Ca2+]i)和膜电位发生了改变;小鼠胸腺细胞中的[Ca2+]i增加,而脾细胞则表现出膜超极化。此外,在UDMH存在的情况下,体外伴刀豆球蛋白A刺激小鼠脾细胞24小时和48小时诱导的白细胞介素-2受体表达未受影响。UDMH可能会干扰这两种不同淋巴细胞群体调节正常离子波动的能力,从而导致免疫反应性改变。

相似文献

1
Evaluation of murine lymphocyte membrane potential, intracellular free calcium, and interleukin-2 receptor expression upon exposure to 1,1-dimethylhydrazine.暴露于1,1-二甲基肼后对小鼠淋巴细胞膜电位、细胞内游离钙和白细胞介素-2受体表达的评估。
Toxicol Lett. 1992 Jun;61(1):27-37. doi: 10.1016/0378-4274(92)90060-w.
2
Enhancement of murine mixed lymphocyte response by 1,1-dimethylhydrazine: characterization and possible mechanism.1,1-二甲基肼对小鼠混合淋巴细胞反应的增强作用:特性及可能机制
Cancer Detect Prev. 1988;12(1-6):573-81.
3
Effect of 1,1-dimethylhydrazine (UDMH) on Corynebacterium parvum-associated immunosuppression in mice.
Int J Immunopharmacol. 1992 Jan;14(1):27-34. doi: 10.1016/0192-0561(92)90101-p.
4
Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression.淋巴细胞中的促黄体生成素释放激素信号传导涉及白细胞介素-2受体表达的刺激。
Endocrinology. 1991 Jul;129(1):277-86. doi: 10.1210/endo-129-1-277.
5
Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats.
Endocrinology. 1991 Aug;129(2):983-90. doi: 10.1210/endo-129-2-983.
6
Effect of 1,1-dimethylhydrazine on lymphoproliferation and interleukin 2 immunoregulatory function.
Arch Environ Contam Toxicol. 1990 Jan-Feb;19(1):148-53. doi: 10.1007/BF01059824.
7
The in vitro and in vivo effects of 1,1-dimethylhydrazine (UDMH) on murine lymphocyte subsets and Ia antigen expression.偏二甲肼(UDMH)对小鼠淋巴细胞亚群及Ia抗原表达的体内外效应
Immunopharmacol Immunotoxicol. 1991;13(1-2):25-46. doi: 10.3109/08923979109019689.
8
In vivo and in vitro effects of 1,1-dimethylhydrazine on selected immune functions.1,1 - 二甲基肼对选定免疫功能的体内和体外作用
Immunopharmacology. 1982 Apr;4(2):139-47. doi: 10.1016/0162-3109(82)90016-9.
9
The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro.触发信号决定了二十二碳六烯酸在体外对淋巴细胞功能的影响。
Lipids. 1998 Sep;33(9):869-78. doi: 10.1007/s11745-998-0283-x.
10
Beta-endorphin inhibits interleukin-2 release and expression of interleukin-2 receptors in concanavalin A-stimulated splenic lymphocytes.β-内啡肽可抑制伴刀豆球蛋白A刺激的脾淋巴细胞中白细胞介素-2的释放及白细胞介素-2受体的表达。
Lymphokine Cytokine Res. 1992 Dec;11(6):339-45.

引用本文的文献

1
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells.CTPS1 和 ATR 的联合失活对 MYC 过表达的癌细胞具有合成致死作用。
Cancer Res. 2022 Mar 15;82(6):1013-1024. doi: 10.1158/0008-5472.CAN-21-1707.